Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/17/2025

Prazosin's Effects on Sleep and Alertness

Understanding Prazosin's Paradoxical Effects

  • Patients treated with prazosin for PTSD-related nightmares report feeling more rested on awakening and experience less daytime fatigue and sleepiness after successful nightmare treatment, according to the American Academy of Sleep Medicine 1
  • Prazosin reduces CNS adrenergic activity, which decreases nightmare frequency and intensity rather than acting as a traditional sedative, as reported by the American Academy of Sleep Medicine 1, 2

Clinical Context and Dosing Considerations

  • Prazosin is typically administered at bedtime, starting at 1 mg and gradually increasing by 1-2 mg every few days until reaching an effective dose, which helps minimize daytime drowsiness, as recommended by the American Academy of Sleep Medicine 1, 2

Monitoring Recommendations

  • Blood pressure should be monitored after the initial dose and with each significant dose increase to distinguish hypotension-related symptoms from true sedation, as suggested by the American Academy of Sleep Medicine and other guideline societies 3
  • Clinicians should specifically assess for orthostatic hypotension, especially after the first dose, as this can cause symptoms that overlap with drowsiness, according to the American Academy of Sleep Medicine 1, 5

REFERENCES

1

best practice guide for the treatment of nightmare disorder in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010

2

best practice guide for the treatment of nightmare disorder in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010

3

Prazosin in Clinical Practice for Hypertension and PTSD-Related Nightmares [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Prazosin-Induced Hypotension [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025